A big challenge with all medical device manufacturers is to be compliant with any regulations applicable with their product. In the case of the United States it will include 21 CFR Part 820 which is a set of regulations from the FDA that outlines the current good manufacturing practice (CGMP) requirements that manufacturers must follow with regards to their quality system. Register for this free webinar where Anne Holland, CEO of QA Consulting with 20+ years experience advising medical device companies on regulatory and quality needs, will share some preventative actions that your medical device company can take to minimize the possibility of receiving a 483 which in some cases could result in a product seizure.
All day: NAMSA Training Series: Biological Safety – Course A
All day June 14, 2022 – June 15, 2022
NAMSA’s Biological Safety Training Series is geared toward medical device professionals who require a working knowledge of biological safety and biocompatibility.
All day: NAMSA Training Series: Biological Safety – Course A
All day June 14, 2022 – June 15, 2022
NAMSA’s Biological Safety Training Series is geared toward medical device professionals who require a working knowledge of biological safety and biocompatibility.
All day: NAMSA Training Series: Biological Safety – Course B
All day June 28, 2022 – June 29, 2022
This two-day training course is designed for those who have received certification in the NAMSA Training Series Biocompatibility of Medical Devices – Two-Day Certification (Course A).
All day: NAMSA Training Series: Biological Safety – Course B
All day June 28, 2022 – June 29, 2022
This two-day training course is designed for those who have received certification in the NAMSA Training Series Biocompatibility of Medical Devices – Two-Day Certification (Course A).